ABCA12 regulates insulin secretion from β-cells.

Gloria M Ursino; Ying Fu; Denny L Cottle; Nigora Mukhamedova; Lynelle K Jones; Hann Low; Ming Shen Tham; Wan Jun Gan; Natalie A Mellett; Partha P Das; Jacquelyn M Weir; Michael Ditiatkovski; Stacey Fynch; Peter Thorn; Helen E Thomas; Peter J Meikle; Helena C Parkington; Ian M Smyth; Dmitri Sviridov
Abstract
Dysregulation of lipid homeostasis is intimately associated with defects in insulin secretion, a key feature of type 2 diabetes. Here, we explore the role of the putative lipid transporter ABCA12 in regulating insulin secretion from β-cells. Mice with β-cell-specific deletion of Abca12 display impaired glucose-stimulated insulin secretion and eventual islet inflammation and β-cell death. ABCA12's action in the pancreas is independent of changes in the abundance of two other cholesterol transporters, ABCA1 and ABCG1, or of changes in cellular cholesterol or ceramide content. Instead, loss of ABCA12 results in defects in the genesis and fusion of insulin secretory granules and increases in the abundance of lipid rafts at the cell membrane. These changes are associated with dysregulation of the small GTPase CDC42 and with decreased actin polymerisation. Our findings establish a new, pleiotropic role for ABCA12 in regulating pancreatic lipid homeostasis and insulin secretion.
Journal EMBO REPORTS
ISSN 1469-3178
Published 04 Mar 2020
Volume 21
Issue 3
Pages e48692
DOI 10.15252/embr.201948692
Type Journal Article
Sponsorship NHMRC: 1036352; NHMRC: 1019847